Sanofi (LON: 0O59)

Market Cap	104.31B
Revenue (ttm)	40.31B
Net Income (ttm)	3.75B
Shares Out	n/a
EPS (ttm)	2.99
PE Ratio	27.82
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	May 13, 2024

Volume	272,852
Average Volume	537,775
Open	99.52
Previous Close	99.02
Day's Range	98.71 - 99.60
52-Week Range	70.18 - 87.94
Beta	0.45
RSI	67.27
Earnings Date	Jan 30, 2025

About Sanofi

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, Canada, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as DUPIXENT, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric ...

• Industry: Pharmaceutical Preparations
• Founded: 1994
• Employees: 86,088
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0O59

Financial Performance

In 2023, Sanofi's revenue was 46.03 billion, an increase of 1.42% compared to the previous year's 45.39 billion. Earnings were 5.40 billion, a decrease of -35.49%.

Financial numbers in EUR